ESC Meeting to Present Key Statin Trial and Heart Attack Care Studies
The European Society of Cardiology meeting will unveil results from the STAREE trial, which examined statin use for primary prevention in adults aged 70 and older. Other studies will address heart attack triage and new anticoagulant therapies, including the failed milvexian trial. The findings are expected to inform clinical decisions for millions of older adults.
Related stories
Cardiology meeting set to reveal competitive landscape for heart therapies · Drug development
Statins Linked to Fewer Pneumonia Hospitalizations but More Flu-Like Illness in Primary Care · Infectious disease
Upcoming readouts expected for experimental cardiovascular drug class · Drug development
Melanoma Vaccine Shows Promise Amid Scrutiny of Chinese Trials · Cancer research
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “To Face Scrutiny at ESC: Statins for the Elderly, New Heart Attack Therapies.” Browse more stories.